Email communication consent

Aspen Pharmacare Australia Pty Ltd requests your consent to communicate with you by email.

Aspen will only use your email address to send information, invitations and offer services such as educational literature, safety related information, invitations to educational events, information about Aspen pharmaceutical products, programs, clinical tools, questionnaires / surveys which are relevant to your therapeutic areas of interest.

Aspen will not provide your email address to third parties except where that third party has been contracted to provide one of the services outlined above on Aspen’s behalf. Aspen and its contractors will comply with the Aspen Privacy Policy which can be accessed at: https://aspenpharma.com.au/privacy/

Should you choose to unsubscribe in the future, Aspen will only continue to use your email to communicate important safety information such as product recalls or safety alerts, supply issues, Therapeutic Goods of Australia (TGA) mandated communications or similar essential communications.

Our privacy policy sets out how we hold, use and disclose your personal information, and how you can ask us to update or remove your personal information.

Aspen Australia includes Aspen Pharmacare Australia Pty Ltd (ABN 51 096 236 985) and Aspen Pharma Pty Ltd (ABN 88 004 118 594). 34-36 Chandos Street, St Leonards NSW 2065. Tel: +61 2 8436 8300. Email: aspen@aspenpharmacare.com.au. Website: www.aspenpharma.com.au
AU-REG-07-25-00003